TUBG1 and AL amyloidosis: In addition, Dementyeva et al. (2013) found that in case of multiple myeloma, patients with positive centrosome amplification showed lower TUBG1 expression levels, reporting better prognosis for centrosome amplification-positive newly diagnosed patients.